Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Goodwill (2016 - 2025)

Historic Goodwill for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to $16.0 billion.

  • Teva Pharmaceutical Industries' Goodwill rose 563.15% to $16.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.0 billion, marking a year-over-year increase of 563.15%. This contributed to the annual value of $16.0 billion for FY2025, which is 563.15% up from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Goodwill of $16.0 billion as of Q4 2025, which was up 563.15% from $15.9 billion recorded in Q3 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Goodwill peaked at $20.4 billion during Q2 2021, and registered a low of $479.0 million during Q2 2022.
  • Moreover, its 5-year median value for Goodwill was $17.1 billion (2023), whereas its average is $16.6 billion.
  • In the last 5 years, Teva Pharmaceutical Industries' Goodwill plummeted by 9765.44% in 2022 and then soared by 347369.52% in 2023.
  • Over the past 5 years, Teva Pharmaceutical Industries' Goodwill (Quarter) stood at $17.6 billion in 2021, then decreased by 2.59% to $17.2 billion in 2022, then changed by 0.0% to $17.2 billion in 2023, then fell by 11.82% to $15.1 billion in 2024, then rose by 5.63% to $16.0 billion in 2025.
  • Its Goodwill was $16.0 billion in Q4 2025, compared to $15.9 billion in Q3 2025 and $15.9 billion in Q2 2025.